BPG is committed to discovery and dissemination of knowledge
Articles in Press
5/29/2025 7:04:39 AM | Browse: 26 | Download: 0
Publication Name World Journal of Gastrointestinal Oncology
Manuscript ID 106723
Country China
Category Immunology
Manuscript Type Minireviews
Article Title Adoptive cell therapy in colorectal cancer: Focus on chimeric antigen receptor T cells
Manuscript Source Invited Manuscript
All Author List Meng-Yan Chen, Chen Wang, Yu-Gang Wang and Min Shi
Funding Agency and Grant Number
Funding Agency Grant Number
Natural Science Foundation of the Science and Technology Commission of Shanghai Municipality, China No. 23ZR1458300
Key Discipline Project of Shanghai Municipal Health System, China No. 2024ZDXK0004
Doctoral Innovation Talent Base Project for Diagnosis and Treatment of Chronic Liver Diseases, China No. RCJD2021B02
Pujiang Project of Shanghai Magnolia Talent Plan, China No. 24PJD098
Corresponding Author Min Shi, Chief Physician, MD, Department of Gastroenterology, Tongren Hospital, Shanghai Jiao Tong University School of Medicine, No. 1111 Xianxia Road, Changning District, Shanghai 200336, China. sm1790@shtrhospital.com
Key Words Colorectal cancer; Adoptive cell therapy; Immunotherapy; Chimeric antigen receptor T cells; Tumor-infiltrating lymphocytes; T-cell receptor-engineered T cells
Core Tip This review discusses adoptive cell therapy approaches for colorectal cancer (CRC), emphasizing chimeric antigen receptor (CAR) T cell therapy. Despite its success in hematological malignancies, CAR-T therapy faces challenges in solid tumors like CRC, including antigen heterogeneity, tumor microenvironment immunosuppression, and on-target off-tumor toxicity. The review explores combinatorial strategies, such as immune checkpoint inhibitors and clustered regularly interspaced short palindromic repeats/Cas9 gene editing, to overcome these challenges and enhance CAR-T cell specificity, resistance to immunosuppressive signals, and in vivo functionality.
Citation Chen MY, Wang C, Wang YG, Shi M. Adoptive cell therapy in colorectal cancer: Focus on chimeric antigen receptor T cells. World J Gastrointest Oncol 2025; In press
Received
2025-03-06 09:04
Peer-Review Started
2025-03-06 09:04
To Make the First Decision
Return for Revision
2025-03-26 11:19
Revised
2025-04-07 10:27
Second Decision
2025-05-29 02:49
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief
2025-05-29 07:04
Articles in Press
2025-05-29 07:04
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
ISSN 1948-5204 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com